Investors blinded by over-optimism on vaccine rollout must see these risks, warns economist

Dow Jones2021-03-10
Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns this economist.

Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns a leading economist.

Taimur Baig, chief economist at Singapore's DBS bank questions "are we getting ahead of ourselves in beginning to look past the pandemic?" Already, he notes, that bond yields have been firming "in expectation of strong growth."

He warns, in countries like the U.S., where vaccination pace has picked up, there will be a tendency among the population to let their guard down, and give up on wearing masks and social-distance requirements, causing a resurgence in infections.

"Outside of a few developed countries, the rate of vaccination is meager at the present stage", he wrote in a Mar. 8 note. "Vaccination-driven herd immunity is many months, if not years, away. Particularly worrisome is that with virus raging through the globe over the past year, a few potent variants have emerged."

He says easing up on protective measures when variants are spreading could prove to be a huge mistake in the coming months, and says mask wearing and social distancing is absolutely critical.

"Otherwise, we are concerned that the SARS-Cov2 variants could end up making the market's normalization trades look highly premature," he warned.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment